Skip to main content

Advertisement

SpringerLink
Log in

Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Increased expression of tissue factor (TF) is associated with tumor invasion and metastasis in human colorectal cancer. We have previously observed that TF/FVIIa upregulates matrix metalloproteinase-7 (MMP-7) expression at the transcriptional level in colon cancer cells. MMP-7 overexpression is believed to play an important role in tumor invasion and metastasis. The aim of this study is to elucidate the molecular mechanisms by which TF/FVIIa induced MMP-7 expression and cell invasion in vitro.

Methods

Reverse transcription polymerase chain reaction, Western blot, luciferase assay, and chromatin immunoprecipitation (ChIP) were used to determine the potential mechanism and signaling pathways by which TF/FVIIa induced MMP-7 expression and cell invasion in LoVo cells. Small interfering RNA (siRNA) and cell invasion assay was used to examine whether blocking c-Fos expression could abolish FVIIa-mediated upregulation of MMP-7 and cell invasion in vitro.

Results

The results showed that FVIIa induced the upregulation of MMP-7 both at the mRNA and protein levels in a time- and dose-dependent manner and increased the invasive behavior of LoVo cells. FVIIa enhanced the promoter activity of MMP-7, and the activator protein-1 (AP-1) binding site was responsible for the activation. Site mutation of the AP-1 binding site in the promoter almost completely abolished FVIIa-mediated response. Furthermore, ChIP assay confirmed that FVIIa promoted the direct binding of c-Fos with the MMP-7 promoter in vivo. FVIIa also induced the expression and nuclear accumulation of the AP-1 subunit c-Fos. siRNA-mediated knockdown of c-Fos eliminated FVIIa-stimulated MMP-7 expression and cell migration in vitro. In addition, selective mitogen-activated protein kinase (MAPK) kinase (MEK1/2) inhibitor (PD98059) and p38 MAPK inhibitor SB203580 suppressed MMP-7 upregulation induced by FVIIa.

Conclusions

Our data suggest that a novel TF/FVIIa/MAPK/c-Fos/MMP-7 axis plays an important role in modulating the invasion of colon cancer cells and blockage of this pathway holds promise to treat colon cancer metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mackman N (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24:1015–1022

    Article  PubMed  CAS  Google Scholar 

  2. Rickles FR, Hair GA, Zeff RA, Lee E, Bona RD (1995) Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 74:391–395

    PubMed  CAS  Google Scholar 

  3. Kasthuri RS, Taubman MB, Mackman N (2009) Role of tissue factor in cancer. J Clin Oncol 27:4834–4838

    Article  PubMed  CAS  Google Scholar 

  4. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC (1995) Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 82:1101–1104

    Article  PubMed  CAS  Google Scholar 

  5. Rak J, Milsom C, May L, Klement P, Yu J (2006) Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 32:54–70

    Article  PubMed  CAS  Google Scholar 

  6. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S, Shiku H (2002) Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69:247–254

    Article  PubMed  CAS  Google Scholar 

  7. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:1734–1741

    Article  PubMed  CAS  Google Scholar 

  8. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, Imamura M (2000) Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 88:295–301

    Article  PubMed  CAS  Google Scholar 

  9. Lykke J, Nielsen HJ (2003) The role of tissue factor in colorectal cancer. Eur J Surg Oncol 29:417–422

    Article  PubMed  CAS  Google Scholar 

  10. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260–1270

    Article  PubMed  CAS  Google Scholar 

  11. Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16–27

    Article  PubMed  CAS  Google Scholar 

  12. Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27:5287–5297

    Article  PubMed  CAS  Google Scholar 

  13. Tan X, Egami H, Abe M, Nozawa F, Hirota M, Ogawa M (2005) Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. J Clin Pathol 58:1242–1248

    Article  PubMed  CAS  Google Scholar 

  14. Wang FQ, So J, Reierstad S, Fishman DA (2005) Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114:19–31

    Article  PubMed  CAS  Google Scholar 

  15. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, Imai K (2001) Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 95:290–294

    Article  PubMed  CAS  Google Scholar 

  16. Maurel J, Nadal C, Garcia-Albeniz X, Gallego R, Carcereny E, Almendro V, Mármol M, Gallardo E, Maria Augé J, Longarón R, Martínez-Fernandez A, Molina R, Castells A, Gascón P (2007) Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 121:1066–1071

    Article  PubMed  CAS  Google Scholar 

  17. Wang WS, Chen PM, Wang HS, Liang WY, Su Y (2006) Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 27:1113–1120

    Article  PubMed  CAS  Google Scholar 

  18. Zhang JQ, Wan YL, Liu YC, Wang X, Tang JQ, Wu T, Zhu J, Pan YS (2008) The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro. Int J Colorectal Dis 23:971–978

    Article  PubMed  Google Scholar 

  19. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231:20–27

    CAS  Google Scholar 

  20. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M, Imai K (1999) Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59:3313–3316

    PubMed  CAS  Google Scholar 

  21. Aihara R, Mochiki E, Nakabayashi T, Akazawa K, Asao T, Kuwano H (2005) Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma. Br J Surg 92:454–462

    Article  PubMed  CAS  Google Scholar 

  22. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45:252–258

    Article  PubMed  CAS  Google Scholar 

  23. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269–285

    Article  PubMed  CAS  Google Scholar 

  24. Jochum W, Passegué E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401–2412

    Article  PubMed  CAS  Google Scholar 

  25. Yuan G, Qian L, Song L, Shi M, Li D, Yu M, Hu M, Shen B, Guo N (2008) Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells. Mol Cell Biochem 318:73–79

    Article  PubMed  CAS  Google Scholar 

  26. Kim M, Murakami A, Kawabata K, Ohigashi H (2005) (−)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis 26:1553–1562

    Article  PubMed  CAS  Google Scholar 

  27. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H (2000) Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 275:6580–6585

    Article  PubMed  CAS  Google Scholar 

  28. Camerer E, Rottingen JA, Gjernes E, Larsen K, Skartlien AH, Iversen JG, Prydz H (1999) Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 274:32225–32233

    Article  PubMed  CAS  Google Scholar 

  29. Versteeg HH, Hoedemaeker I, Diks SH, Stam JC, Spaargaren M, van Bergen En Henegouwen PM, van Deventer SJ, Peppelenbosch MP (2000) Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. J Biol Chem 275:28750–28756

    Article  PubMed  CAS  Google Scholar 

  30. Shen KH, Hung SH, Yin LT, Huang CS, Chao CH, Liu CL, Shih YW (2010) Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem 333:279–291

    Article  PubMed  CAS  Google Scholar 

  31. Chien ST, Lin SS, Wang CK, Lee YB, Chen KS, Fong Y, Shih YW (2011) Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38α MAPK signaling pathway. Mol Cell Biochem 350:135–148

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by grants from the National Natural Sciences Foundation of China (30872469), the National Natural Sciences Youth Foundation of China (30801092), and the “985” Project Foundation of Peking University.

Author information

Authors and Affiliations

  1. Laboratory of Colon Cancer, First Hospital of Peking University, No. 8, Xishiku Street, West District, Beijing, 100034, China

    Zhi-Chao Jia, Yuan-Lian Wan, Jian-Qiang Tang, Yun Dai, Yu-Cun Liu, Xin Wang & Jing Zhu

Authors
  1. Zhi-Chao Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-Lian Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-Qiang Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yun Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-Cun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuan-Lian Wan or Jian-Qiang Tang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, ZC., Wan, YL., Tang, JQ. et al. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Int J Colorectal Dis 27, 437–445 (2012). https://doi.org/10.1007/s00384-011-1351-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1351-0

Keywords

Search

Navigation